Article
08 Aug 2025
PBM Audits: Assessment Of Escalating Trends And Strategies For Pharmacies
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
07 Aug 2025
Major Update On GLP-1 Litigation Involving Compounding Pharmacies
Article
01 Aug 2025
PBMs Double Down On Cross Network Termination Over "Affiliated" Pharmacies
Article
29 Jul 2025
The 340B Drug Pricing Program: Navigating Challenges In Healthcare Access
Article
29 Jul 2025
New Rules To Impact Texas Pharmacies
Article
24 Jul 2025
Victory For DMEPOS Provider: Buchanan Reverses Medicare Enrollment Revocation
Article
03 Jul 2025
Turning The Tide On Prior Authorization: A Legal And Strategic Moment For Independent Pharmacies
Article
19 Jun 2025
Pharmacy Alert: AstraZeneca Sends "Unreserved Cooperation" Letters Demanding Farxiga® Dispensing Records
Article
18 Jun 2025
State Board Of Pharmacy: Ohio GLP-1 Compounders Be Vigilant
Article
10 Jun 2025
Growing Concern For Pennsylvania Pharmacies: The Surge In State Board Inspections And The Collateral Impact On PBM Relationships
Article
03 Jun 2025
PBMs Under Siege: How The Current Administration's 2025 Executive Order And FTC Enforcement Campaign Are Shaping The Future Of Drug Pricing
Article
19 May 2025
Pharmacies On Alert: Gilead Reports Pharmacies To State Boards Over Counterfeit Drug Purchases
Article
19 May 2025
Tirzepatide Ruling: Implications For Compounders In An Evolving Legal Landscape
Article
15 May 2025
Why Pharmacies Must Stay Vigilant On PBM Provider Manual Updates
Article
09 May 2025
PBMs Clamp Down On Diabetic Test Supply Sourcing: Invoice Shortages And Network Terminations On The Rise
Article
07 May 2025
A Blueprint For Action: Michigan's Lawsuit Against Express Scripts And Prime Therapeutics Signals A Turning Point For Independent Pharmacies, Plan Sponsor, Patients, And State Enforcement
Article
01 May 2025
Traditional PBM Model Is Not Suitable For Employers
Article
30 Apr 2025
GLP-1 Litigation Escalates: What Pharmacies And Telemedicine Providers Need To Know
Article
23 Apr 2025
The High Cost Of Trust: What Pharmacies Must Learn From The Rise Of Counterfeit GLP-1 Product Sales
Article
14 Apr 2025
Navigating DEA Red Flags And Corresponding Responsibilities: A Stark Reality For Today's Pharmacies
